156 related articles for article (PubMed ID: 32070431)
1. Age-, tumor-, and metastatic tissue-associated DNA hypermethylation of a T-box brain 1 locus in human kidney tissue.
Serth J; Peters I; Dubrowinskaja N; Reese C; Albrecht K; Klintschar M; Lafos M; Grote A; Becker A; Hennenlotter J; Stenzl A; Tezval H; Kuczyk MA
Clin Epigenetics; 2020 Feb; 12(1):33. PubMed ID: 32070431
[TBL] [Abstract][Full Text] [Related]
2. DNA methylation of neural EGFL like 1 (NELL1) is associated with advanced disease and the metastatic state of renal cell cancer patients.
Peters I; Dubrowinskaja N; Hennenlotter J; Antonopoulos WI; Von Klot CAJ; Tezval H; Stenzl A; Kuczyk MA; Serth J
Oncol Rep; 2018 Dec; 40(6):3861-3868. PubMed ID: 30272321
[TBL] [Abstract][Full Text] [Related]
3. Identification of a Novel Renal Metastasis Associated CpG-Based DNA Methylation Signature (RMAMS).
Serth J; Peters I; Katzendorn O; Dang TN; Moog J; Balli Z; Reese C; Hennenlotter J; Grote A; Lafos M; Tezval H; Kuczyk MA
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232491
[TBL] [Abstract][Full Text] [Related]
4. SFRP1 CpG island methylation locus is associated with renal cell cancer susceptibility and disease recurrence.
Atschekzei F; Hennenlotter J; Jänisch S; Großhennig A; Tränkenschuh W; Waalkes S; Peters I; Dörk T; Merseburger AS; Stenzl A; Kuczyk MA; Serth J
Epigenetics; 2012 May; 7(5):447-57. PubMed ID: 22419128
[TBL] [Abstract][Full Text] [Related]
5. DNA methylation of tumor associated calcium signal transducer 2 (TACSTD2) loci shows association with clinically aggressive renal cell cancers.
Katzendorn O; Peters I; Dubrowinskaja N; Tezval H; Tabrizi PF; von Klot CA; Hennenlotter J; Lafos M; Kuczyk MA; Serth J
BMC Cancer; 2021 Apr; 21(1):444. PubMed ID: 33882870
[TBL] [Abstract][Full Text] [Related]
6. GATA5 CpG island methylation in renal cell cancer: a potential biomarker for metastasis and disease progression.
Peters I; Eggers H; Atschekzei F; Hennenlotter J; Waalkes S; Tränkenschuh W; Grosshennig A; Merseburger AS; Stenzl A; Kuczyk MA; Serth J
BJU Int; 2012 Jul; 110(2 Pt 2):E144-52. PubMed ID: 22289415
[TBL] [Abstract][Full Text] [Related]
7. Methylation of the gamma-catenin gene is associated with poor prognosis of renal cell carcinoma.
Breault JE; Shiina H; Igawa M; Ribeiro-Filho LA; Deguchi M; Enokida H; Urakami S; Terashima M; Nakagawa M; Kane CJ; Carroll PR; Dahiya R
Clin Cancer Res; 2005 Jan; 11(2 Pt 1):557-64. PubMed ID: 15701841
[TBL] [Abstract][Full Text] [Related]
8. Age-Related DNA Methylation in Normal Kidney Tissue Identifies Epigenetic Cancer Risk Susceptibility Loci in the ANKRD34B and ZIC1 Genes.
Serth J; Peters I; Hill B; Hübscher T; Hennenlotter J; Klintschar M; Kuczyk MA
Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628134
[TBL] [Abstract][Full Text] [Related]
9. Tumor Specific Epigenetic Silencing of Corticotropin Releasing Hormone -Binding Protein in Renal Cell Carcinoma: Association of Hypermethylation and Metastasis.
Tezval H; Dubrowinskaja N; Peters I; Reese C; Serth K; Atschekzei F; Hennenlotter J; Stenzl A; Kuczyk MA; Serth J
PLoS One; 2016; 11(10):e0163873. PubMed ID: 27695045
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic silencing of ZBTB28 promotes renal cell carcinogenesis.
Tong X; Xu L; Rong R; Su X; Xiang T; Peng W; Shi T
Asia Pac J Clin Oncol; 2022 Apr; 18(2):e79-e86. PubMed ID: 34161675
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of promoter CpG island methylation of obesity-related genes in patients with nonmetastatic renal cell carcinoma.
Mendoza-Pérez J; Gu J; Herrera LA; Tannir NM; Zhang S; Matin S; Karam JA; Wood CG; Wu X
Cancer; 2017 Sep; 123(18):3617-3627. PubMed ID: 28543182
[TBL] [Abstract][Full Text] [Related]
12. PON1 hypermethylation is associated with progression of renal cell carcinoma.
Li X; Yu Q
J Cell Mol Med; 2019 Oct; 23(10):6646-6657. PubMed ID: 31400051
[TBL] [Abstract][Full Text] [Related]
13. Prognostic and diagnostic relevance of hypermethylated in cancer 1 (HIC1) CpG island methylation in renal cell carcinoma.
Eggers H; Steffens S; Grosshennig A; Becker JU; Hennenlotter J; Stenzl A; Merseburger AS; Kuczyk MA; Serth J
Int J Oncol; 2012 May; 40(5):1650-8. PubMed ID: 22327210
[TBL] [Abstract][Full Text] [Related]
14. CpG dinucleotide-specific hypermethylation of the TNS3 gene promoter in human renal cell carcinoma.
Carter JA; Górecki DC; Mein CA; Ljungberg B; Hafizi S
Epigenetics; 2013 Jul; 8(7):739-47. PubMed ID: 23803643
[TBL] [Abstract][Full Text] [Related]
15. von Hippel-Lindau exonic methylation analysis using MALDI-TOF mass spectrometry.
Lian F; Sreedharan S; Arnold RS; Master VA; Ogan K; Pattaras JG; Roberts DL; Petros JA
J Urol; 2014 Nov; 192(5):1528-33. PubMed ID: 24704013
[TBL] [Abstract][Full Text] [Related]
16. GATA5 CpG island hypermethylation is an independent predictor for poor clinical outcome in renal cell carcinoma.
Peters I; Gebauer K; Dubrowinskaja N; Atschekzei F; Kramer MW; Hennenlotter J; Tezval H; Abbas M; Scherer R; Merseburger AS; Stenzl A; Kuczyk MA; Serth J
Oncol Rep; 2014 Apr; 31(4):1523-30. PubMed ID: 24549248
[TBL] [Abstract][Full Text] [Related]
17. Methylomes of renal cell lines and tumors or metastases differ significantly with impact on pharmacogenes.
Winter S; Fisel P; Büttner F; Rausch S; D'Amico D; Hennenlotter J; Kruck S; Nies AT; Stenzl A; Junker K; Scharpf M; Hofmann U; van der Kuip H; Fend F; Ott G; Agaimy A; Hartmann A; Bedke J; Schwab M; Schaeffeler E
Sci Rep; 2016 Jul; 6():29930. PubMed ID: 27435027
[TBL] [Abstract][Full Text] [Related]
18. Germline and somatic DNA methylation and epigenetic regulation of KILLIN in renal cell carcinoma.
Bennett KL; Campbell R; Ganapathi S; Zhou M; Rini B; Ganapathi R; Neumann HP; Eng C
Genes Chromosomes Cancer; 2011 Aug; 50(8):654-61. PubMed ID: 21584899
[TBL] [Abstract][Full Text] [Related]
19. DNA methylation status defines clinicopathological parameters including survival for patients with clear cell renal cell carcinoma (ccRCC).
Evelönn EA; Degerman S; Köhn L; Landfors M; Ljungberg B; Roos G
Tumour Biol; 2016 Aug; 37(8):10219-28. PubMed ID: 26831665
[TBL] [Abstract][Full Text] [Related]
20. Methylation-associated silencing of TU3A in human cancers.
Awakura Y; Nakamura E; Ito N; Kamoto T; Ogawa O
Int J Oncol; 2008 Oct; 33(4):893-9. PubMed ID: 18813805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
